text stringlengths 0 146 |
|---|
Chronic Adrenal Insufficiency |
(Addison's Disease) |
The coverage of this Special CI conditions benefit will be |
provided until the day before the policy anniversary |
immediately after the life insured's 85th birthday or the benefit |
end date of this policy, whichever is earlier. |
An autoimmune disorder causing a gradual destruction of the |
adrenal gland resulting in the need for life long glucocorticoid |
and mineral corticoid replacement therapy. The disorder must |
be confirmed by a specialist in endocrinology through one of the |
following: |
• ACTH simulation tests; |
• insulin-induced hypoglycemia test; |
• plasma ACTH level measurement; |
• Plasma Renin Activity (PRA) level measurement. |
Only autoimmune cause of primary adrenal insufficiency is |
included. All other causes of adrenal insufficiency are excluded. |
3 |
Chronic Relapsing |
Pancreatitis |
The coverage of this Special CI conditions benefit will be |
provided until the day before the policy anniversary |
immediately after the life insured's 85th birthday or the benefit |
end date of this policy, whichever is earlier. |
More than 3 attacks of pancreatitis resulting in pancreatic |
dysfunction causing malabsorption needing enzyme |
replacement therapy. |
The diagnosis must be made by a consultant gastroenterologist |
and confirmed by Endoscopic Retrograde |
Cholangiopancreatography (ERCP). |
Chronic Relapsing Pancreatitis caused by alcohol use is |
excluded. |
4 |
Dengue Heamorrhagic Fever |
The coverage of this Special CI conditions benefit will be |
provided until the day before the policy anniversary |
immediately after the life insured's 85th birthday or the benefit |
end date of this policy, whichever is earlier. |
Dengue Haemorrhagic Fever Stage 3 or Stage 4, based on the |
World Health Organization case definition (1997), with |
unequivocal evidence of the Dengue Shock Syndrome and |
confirmation of dengue infection, with confirmatory serological |
testing of dengue; and as exemplified by the following findings: |
history of continuous high fever (for two (2) or more days), |
• minor or major haemorrhagic manifestations, |
• thrombocytopenia (less than or equal to 100000 per mm3) |
• haemoconcentration (haemotocrit increased by 20% or more) |
and |
• evidence of plasma leakage (i.e. pleural effusion, ascites or |
hypoproteinaemia, etc.) |
Manulife CI FlexiCare (Deluxe) v0123 |
Page 37 of 42 |
Manulife (Singapore) Pte. Ltd. |
A Manulife Company |
No |
Covered Special CI |
Conditions |
Definition |
• evidence of the Dengue Shock Syndrome (DSS), confirmed by |
a Specialist, with the following criteria being met: |
- hypotension (less than 80 mm Hg) or narrow pulse pressure |
(20 mm Hg or less) and |
- evidence of tissue hypoperfusion such as cold, clammy skin, |
oliguria, or a metabolic acidosis. |
5 |
Diabetic Complications |
The coverage of this Special CI conditions benefit will be |
provided until the day before the policy anniversary |
immediately after the life insured's 85th birthday or the benefit |
end date of this policy, whichever is earlier. |
Diabetic Retinopathy with actual undergoing of laser treatment |
certified to be Medically Necessary by a Specialist with support |
of Fluorescent Fundus Angiography report and vision measured |
at 6/18 or worse in the better eye using a Snellen eye chart |
before the procedure. |
A definite diagnosis of diabetic nephropathy by a Specialist and |
is evident by permanent eGFR less than 30 ml/min/1.73 m2 |
with ongoing proteinuria greater than 300mg/24 hours. |
The actual undergoing of amputation of a leg / foot / toe / arm / |
hand / finger to treat gangrene that has occurred because of a |
complication of diabetes. |
6 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.